Role of Epigenetics and Oxidative Stress in Gliomagenesis

Author(s): Yesennia Sanchez-Perez, Ernesto Soto-Reyes, Claudia M. Garcia-Cuellar, Bernardo Cacho-Diaz, Abel Santamaria, Edgar Rangel-Lopez*

Journal Name: CNS & Neurological Disorders - Drug Targets
Formerly Current Drug Targets - CNS & Neurological Disorders

Volume 16 , Issue 10 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background & Objective: Gliomas constitute 81% of malignant brain tumors and exhibit a poor prognosis. Two main events involved in the progression of gliomas are the deregulation of genes via genetic events and the cellular damage resulting from the formation of reactive oxygen species (ROS). In gliomas, epigenetic abnormalities implicated in the deregulation of deoxyribonucleic acid (DNA) methylation, nucleosome rearrangement, and acetylation of histones, have been depicted. The overproduction of ROS has been implicated in the promotion of these modifications.

Conclusion: In this review, we discuss the epigenetic mechanisms and oxidative events that impact gene silencing and its association with the establishment and development of gliomas. Some of these epigenetic marks, or their related proteins, are under investigation for their potential use as biomarkers in clinical trials to propose personalized therapies for patients with glioblastoma.

Keywords: Brain tumors, clinical trials, epigenetics, glioma, malignant, oxidative stress.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [1090 - 1098]
Pages: 9
DOI: 10.2174/1871527317666180110124645
Price: $65

Article Metrics

PDF: 40